NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock
NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3080% below fair value
$0.71−0.04 (-5.15%)
Close on Nov 17, 2026Market cap $6.43MP/E –Yield –
Neuroone Medical Technologies revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Neuroone Medical Technologies's revenue for the twelve months ending Jun 30, 2026 was $9.47M, up 42.8% year over year. For fiscal 2025 it was $9.10M, up 163.5% from the year before. Over ten years it grew 110.2% a year on average. The highest annual figure on record is $9.10M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $9.10M | +163.5% |
| FY2024 | Sep 30, 2024 | $3.45M | +76.9% |
| FY2023 | Sep 30, 2023 | $1.95M | +1040.7% |
| FY2022 | Sep 30, 2022 | $171.17K | -3.9% |
| FY2021 | Sep 30, 2021 | $178.15K | – |
| FY2016 | Dec 31, 2016 | $0 | – |
| FY2015 | Dec 31, 2015 | $0 | -100.0% |
| FY2014 | Dec 31, 2014 | $773 | -38.1% |
| FY2013 | Dec 31, 2013 | $1.25K | +35.6% |
| FY2012 | Dec 31, 2012 | $921 | -82.9% |
| FY2011 | Dec 31, 2011 | $5.40K | +362.6% |
| FY2010 | Dec 31, 2010 | $1.17K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $1.97M | +16.3% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $1.86M | +34.3% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $2.89M | -11.7% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $2.74M | +906.6% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $1.70M | +105.4% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $1.39M | +0.7% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $3.27M | +234.9% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $272.28K | -63.3% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $825.78K | +31.1% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $1.38M | +195.4% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $977.65K | +753.3% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $741.78K | +978.4% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $629.91K | +1865.4% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $466.18K | +1174.3% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $114.58K | +239.5% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $68.79K | +42.3% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $32.05K | -20.1% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $36.58K | +100.6% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $33.75K | -52.8% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $48.34K | – |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $40.10K | – |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $18.24K | – |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $71.47K | – |
| Q2 FY2017CQ2 2017 | Jun 30, 2017 | $0 | – |
| Q1 FY2017CQ1 2017 | Mar 31, 2017 | $0 | – |
| Q4 FY2016CQ4 2016 | Dec 31, 2016 | $0 | – |
| Q3 FY2016CQ3 2016 | Sep 30, 2016 | $0 | – |
| Q2 FY2016CQ2 2016 | Jun 30, 2016 | $0 | – |
| Q1 FY2016CQ1 2016 | Mar 31, 2016 | $0 | -100.0% |
| Q4 FY2015CQ4 2015 | Dec 31, 2015 | $0 | -100.0% |
| Q3 FY2015CQ3 2015 | Sep 30, 2015 | $0 | – |
| Q2 FY2015CQ2 2015 | Jun 30, 2015 | $0 | – |
| Q1 FY2015CQ1 2015 | Mar 31, 2015 | $113 | – |
| Q4 FY2014CQ4 2014 | Dec 31, 2014 | $166 | – |
See a number that looks wrong?